欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0541/001
药品名称Rhesonativ
活性成分
    • human anti-D immunoglobulin 625.0 IU/ml
剂型Solution for injection
上市许可持有人Octapharma AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Portugal (PT)
      Rhesonativ
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Rhesonativ
    • Latvia (LV)
      Rhesonativ 625 SV/ml šķīdums injekcijām
    • Lithuania (LT)
      Rhesonativ 625 TV/ml injekcinis tirpalas
    • Estonia (EE)
      RHESONATIV
    • Hungary (HU)
      Rhesonativ 625 NE/ml oldatos injekció
    • Cyprus (CY)
      25M0179
    • Czechia (CZ)
      12350/06
    • Romania (RO)
      Rhesonativ 625 UI/ml solutie injectabila
    • Slovakia (SK)
      Rhesonativ
    • Slovenia (SI)
    • Austria (AT)
      Rhesonativ 625 I.E./ml Injektionslösung
    • France (FR)
    • Italy (IT)
    • Bulgaria (BG)
    • Malta (MT)
许可日期2006/03/06
最近更新日期2024/01/26
药物ATC编码
    • J06BB01 anti-D (rh) immunoglobulin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier [Article 8.3(i)]
  • TypeLevel4：Biological: Blood Product
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase